Investigating the medical journey of endometriosis-affected women: Results from a cross-sectional web-based survey (EndoVie) on 1,557 French women
article
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Adenomyosis of the inner and outer myometrium are associated with different clinical profiles via openalex
- A new validated screening method for endometriosis diagnosis based on patient questionnaires via openalex
- Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis via openalex
- Delayed diagnosis of endometriosis disadvantages women in ART: a retrospective population linked data study via openalex
- Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences via openalex
- Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via openalex
- Evaluation of quality of life in fertile Turkish women with severe endometriosis via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study via openalex
- <p>Research on central sensitization of endometriosis-associated pain: a systematic review of the literature</p> via openalex
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? via openalex
- Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity via openalex
- Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis via openalex
- Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The definition of Endometriosis Expert Centres via openalex
- The Pain and Daily Consequences of Living with Endometriosis: A Qualitative Online Survey of Women in China, France and Russia via openalex
- W6604186803 via openalex
- W6687823890 via openalex
- W6786464634 via openalex
- W3082813390 via openalex
- W3087820513 via openalex
- W3109171682 via openalex
- W3119380823 via openalex
- W3162248259 via openalex
- W4207024966 via openalex
Cited by (6)
- Endometriosis Diagnostic Delay and Its Correlates: Results from the ComPaRe-Endometriosis Cohort 2025
- Bridging the Care Gap in Endometriosis: A Qualitative Study of Tele-Patient-Reported Outcome Measures (telePROM) in Outpatient Follow-Up 2025
- Impact of a National Public Health Plan on the time frame for moderate and severe endometriosis diagnosis 2025
- Benign gynecological diseases and women’s health burden: time to remove the invisibility cloak 2025
- Holistic approach to care for patients with endometriosis 2024
- “Ladies first”: a plea for prioritizing women’s inclusion in the research and health care agenda 2024
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:33:16.146570+00:00
License: CC0
· commercial use OK